Načítá se...
Early- and late anthracycline-induced cardiac dysfunction: echocardiographic characterization and response to heart failure therapy
BACKGROUND: Anthracycline-induced cardiac dysfunction (ACD) is a notorious side effect of anticancer treatment. It has been described as a phenomenon of a continuous progressive decline of cardiac function, eventually leading to dilated cardiomyopathy (DCM). This progressive nature suggests that pat...
Uloženo v:
| Vydáno v: | Cardiooncology |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7557080/ https://ncbi.nlm.nih.gov/pubmed/33072403 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40959-020-00079-3 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|